Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1994 Jul;1(4):450–463. doi: 10.1128/cdli.1.4.450-463.1994

Evaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulin.

S Tzipori 1, W Rand 1, J Griffiths 1, G Widmer 1, J Crabb 1
PMCID: PMC368287  PMID: 8556484

Abstract

Several immunodeficient rodent models currently exist in which persistent, largely asymptomatic, Cryptosporidium parvum infections can be established. Piglets, in contrast, develop a self-limiting diarrheal illness. We have consequently developed an animal model system in which scid mice were used to screen drugs for inhibitory activity against C. parvum, after which the drugs' therapeutic potential was evaluated with piglets. Paromomycin and hyperimmune bovine colostrum-immunoglobulin were selected to evaluate this system. C. paravum infections in suckling scid mice tended to be associated with villus surfaces, while in weaned and in older scid mice infections were more commonly localized in abscessed crypts. Rates of oocyst shedding in suckling scid mice were 50 to 200 times higher than in weaned mice and therefore made suckling mice a considerably more sensitive model for drug testing. Paromomycin given in high doses over 9 to 10 days was not toxic to either scid mice (3,000 mg/kg of body weight per day) or piglets (500 mg/kg/day). Paromomycin treatment was very effective against villus surface infections in suckling mice and considerably less effective against infections in inaccessible sites such as abscessed crypts and stomach pits seen in weaned and adult scid mice. The therapeutic efficacy of paromomycin in piglets depended on the severity of the diarrheal illness. Mild to moderate diarrhea and infection were cleared after paromomycin treatment of piglets infected with one C. parvum isolate. However, paromomycin had no impact on severely affected piglets infected with a second isolate, presumably because of a rapid transit time through the gut. In contrast to paromomycin hyperimmune bovine colostrum-immunoglobulin treatment reduced the rate of C. parvum infection moderately in scid mice and only slightly in piglets, again probably because of a rapid transit time through the gut and inactivation in the stomach. It was also clear that the impact of effective drugs against C. parvum can be detected within 5 days after the onset of treatment in either model.

Full text

PDF
450

Images in this article

455Image
on p.455
456Image
on p.456
457Image
on p.457
458Image
on p.458
460Image
on p.460
461Image
on p.461

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Addiss D. G., Stewart J. M., Finton R. J., Wahlquist S. P., Williams R. M., Dickerson J. W., Spencer H. C., Juranek D. D. Giardia lamblia and Cryptosporidium infections in child day-care centers in Fulton County, Georgia. Pediatr Infect Dis J. 1991 Dec;10(12):907–911. doi: 10.1097/00006454-199112000-00005. [DOI] [PubMed] [Google Scholar]
  2. Armitage K., Flanigan T., Carey J., Frank I., MacGregor R. R., Ross P., Goodgame R., Turner J. Treatment of cryptosporidiosis with paromomycin. A report of five cases. Arch Intern Med. 1992 Dec;152(12):2497–2499. [PubMed] [Google Scholar]
  3. Arrowood M. J., Mead J. R., Mahrt J. L., Sterling C. R. Effects of immune colostrum and orally administered antisporozoite monoclonal antibodies on the outcome of Cryptosporidium parvum infections in neonatal mice. Infect Immun. 1989 Aug;57(8):2283–2288. doi: 10.1128/iai.57.8.2283-2288.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blanshard C., Jackson A. M., Shanson D. C., Francis N., Gazzard B. G. Cryptosporidiosis in HIV-seropositive patients. Q J Med. 1992 Nov-Dec;85(307-308):813–823. [PubMed] [Google Scholar]
  5. Current W. L., Garcia L. S. Cryptosporidiosis. Clin Microbiol Rev. 1991 Jul;4(3):325–358. doi: 10.1128/cmr.4.3.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Doyle P. S., Crabb J., Petersen C. Anti-Cryptosporidium parvum antibodies inhibit infectivity in vitro and in vivo. Infect Immun. 1993 Oct;61(10):4079–4084. doi: 10.1128/iai.61.10.4079-4084.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fayer R., Andrews C., Ungar B. L., Blagburn B. Efficacy of hyperimmune bovine colostrum for prophylaxis of cryptosporidiosis in neonatal calves. J Parasitol. 1989 Jun;75(3):393–397. [PubMed] [Google Scholar]
  8. Fayer R., Ellis W. Glycoside antibiotics alone and combined with tetracyclines for prophylaxis of experimental cryptosporidiosis in neonatal BALB/c mice. J Parasitol. 1993 Aug;79(4):553–558. [PubMed] [Google Scholar]
  9. Fayer R., Guidry A., Blagburn B. L. Immunotherapeutic efficacy of bovine colostral immunoglobulins from a hyperimmunized cow against cryptosporidiosis in neonatal mice. Infect Immun. 1990 Sep;58(9):2962–2965. doi: 10.1128/iai.58.9.2962-2965.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fayer R., Perryman L. E., Riggs M. W. Hyperimmune bovine colostrum neutralizes Cryptosporidium sporozoites and protects mice against oocyst challenge. J Parasitol. 1989 Feb;75(1):151–153. [PubMed] [Google Scholar]
  11. Ferson M. J., Young L. C. Cryptosporidium and coxsackievirus B5 causing epidemic diarrhoea in a child-care centre. Med J Aust. 1992 Jun 1;156(11):813–813. doi: 10.5694/j.1326-5377.1992.tb121578.x. [DOI] [PubMed] [Google Scholar]
  12. Fichtenbaum C. J., Ritchie D. J., Powderly W. G. Use of paromomycin for treatment of cryptosporidiosis in patients with AIDS. Clin Infect Dis. 1993 Feb;16(2):298–300. doi: 10.1093/clind/16.2.298. [DOI] [PubMed] [Google Scholar]
  13. Flanigan T., Marshall R., Redman D., Kaetzel C., Ungar B. In vitro screening of therapeutic agents against Cryptosporidium: hyperimmune cow colostrum is highly inhibitory. J Protozool. 1991 Nov-Dec;38(6):225S–227S. [PubMed] [Google Scholar]
  14. Goodgame R. W., Genta R. M., White A. C., Chappell C. L. Intensity of infection in AIDS-associated cryptosporidiosis. J Infect Dis. 1993 Mar;167(3):704–709. doi: 10.1093/infdis/167.3.704. [DOI] [PubMed] [Google Scholar]
  15. Harp J. A., Woodmansee D. B., Moon H. W. Effects of colostral antibody on susceptibility of calves to Cryptosporidium parvum infection. Am J Vet Res. 1989 Dec;50(12):2117–2119. [PubMed] [Google Scholar]
  16. Heine J., Moon H. W., Woodmansee D. B. Persistent Cryptosporidium infection in congenitally athymic (nude) mice. Infect Immun. 1984 Mar;43(3):856–859. doi: 10.1128/iai.43.3.856-859.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Louie E., Borkowsky W., Klesius P. H., Haynes T. B., Gordon S., Bonk S., Lawrence H. S. Treatment of cryptosporidiosis with oral bovine transfer factor. Clin Immunol Immunopathol. 1987 Sep;44(3):329–334. doi: 10.1016/0090-1229(87)90077-8. [DOI] [PubMed] [Google Scholar]
  18. Marshall R. J., Flanigan T. P. Paromomycin inhibits Cryptosporidium infection of a human enterocyte cell line. J Infect Dis. 1992 Apr;165(4):772–774. doi: 10.1093/infdis/165.4.772. [DOI] [PubMed] [Google Scholar]
  19. Mead J. R., Arrowood M. J., Sidwell R. W., Healey M. C. Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice. J Infect Dis. 1991 Jun;163(6):1297–1304. doi: 10.1093/infdis/163.6.1297. [DOI] [PubMed] [Google Scholar]
  20. Moskovitz B. L., Stanton T. L., Kusmierek J. J. Spiramycin therapy for cryptosporidial diarrhoea in immunocompromised patients. J Antimicrob Chemother. 1988 Jul;22 (Suppl B):189–191. doi: 10.1093/jac/22.supplement_b.189. [DOI] [PubMed] [Google Scholar]
  21. Perryman L. E., Riggs M. W., Mason P. H., Fayer R. Kinetics of Cryptosporidium parvum sporozoite neutralization by monoclonal antibodies, immune bovine serum, and immune bovine colostrum. Infect Immun. 1990 Jan;58(1):257–259. doi: 10.1128/iai.58.1.257-259.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Petersen C. Cellular biology of Cryptosporidium parvum. Parasitol Today. 1993 Mar;9(3):87–91. doi: 10.1016/0169-4758(93)90211-w. [DOI] [PubMed] [Google Scholar]
  23. Petersen C. Cryptosporidiosis in patients infected with the human immunodeficiency virus. Clin Infect Dis. 1992 Dec;15(6):903–909. doi: 10.1093/clind/15.6.903. [DOI] [PubMed] [Google Scholar]
  24. Pozio E., Gomez Morales M. A., Barbieri F. M., La Rosa G. Cryptosporidium: different behaviour in calves of isolates of human origin. Trans R Soc Trop Med Hyg. 1992 Nov-Dec;86(6):636–638. doi: 10.1016/0035-9203(92)90165-9. [DOI] [PubMed] [Google Scholar]
  25. Rasmussen K. R., Healey M. C. Experimental Cryptosporidium parvum infections in immunosuppressed adult mice. Infect Immun. 1992 Apr;60(4):1648–1652. doi: 10.1128/iai.60.4.1648-1652.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Saxon A., Weinstein W. Oral administration of bovine colostrum anti-cryptosporidia antibody fails to alter the course of human cryptosporidiosis. J Parasitol. 1987 Apr;73(2):413–415. [PubMed] [Google Scholar]
  27. Tzipori S. Cryptosporidiosis in animals and humans. Microbiol Rev. 1983 Mar;47(1):84–96. doi: 10.1128/mr.47.1.84-96.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tzipori S. Cryptosporidiosis in perspective. Adv Parasitol. 1988;27:63–129. doi: 10.1016/S0065-308X(08)60353-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Tzipori S., Roberton D., Chapman C. Remission of diarrhoea due to cryptosporidiosis in an immunodeficient child treated with hyperimmune bovine colostrum. Br Med J (Clin Res Ed) 1986 Nov 15;293(6557):1276–1277. doi: 10.1136/bmj.293.6557.1276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tzipori S., Roberton D., Cooper D. A., White L. Chronic cryptosporidial diarrhoea and hyperimmune cow colostrum. Lancet. 1987 Aug 8;2(8554):344–345. doi: 10.1016/s0140-6736(87)90944-5. [DOI] [PubMed] [Google Scholar]
  31. Ungar B. L., Kao T. C., Burris J. A., Finkelman F. D. Cryptosporidium infection in an adult mouse model. Independent roles for IFN-gamma and CD4+ T lymphocytes in protective immunity. J Immunol. 1991 Aug 1;147(3):1014–1022. [PubMed] [Google Scholar]
  32. Ungar B. L., Soave R., Fayer R., Nash T. E. Enzyme immunoassay detection of immunoglobulin M and G antibodies to Cryptosporidium in immunocompetent and immunocompromised persons. J Infect Dis. 1986 Mar;153(3):570–578. doi: 10.1093/infdis/153.3.570. [DOI] [PubMed] [Google Scholar]
  33. Ungar B. L., Ward D. J., Fayer R., Quinn C. A. Cessation of Cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum. Gastroenterology. 1990 Feb;98(2):486–489. doi: 10.1016/0016-5085(90)90842-o. [DOI] [PubMed] [Google Scholar]
  34. Vítovec J., Koudela B. Pathogenesis of intestinal cryptosporidiosis in conventional and gnotobiotic piglets. Vet Parasitol. 1992 Jun;43(1-2):25–36. doi: 10.1016/0304-4017(92)90045-b. [DOI] [PubMed] [Google Scholar]
  35. Watzl B., Huang D. S., Alak J., Darban H., Jenkins E. M., Watson R. R. Enhancement of resistance to Cryptosporidium parvum by pooled bovine colostrum during murine retroviral infection. Am J Trop Med Hyg. 1993 Apr;48(4):519–523. doi: 10.4269/ajtmh.1993.48.519. [DOI] [PubMed] [Google Scholar]
  36. Weikel C., Lazenby A., Belitsos P., McDewitt M., Fleming H. E., Jr, Barbacci M. Intestinal injury associated with spiramycin therapy of Cryptosporidium infection in AIDS. J Protozool. 1991 Nov-Dec;38(6):147S–147S. [PubMed] [Google Scholar]
  37. Yang S., Healey M. C. The immunosuppressive effects of dexamethasone administered in drinking water to C57BL/6N mice infected with Cryptosporidium parvum. J Parasitol. 1993 Aug;79(4):626–630. [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES